NCT02482454Active, not recruitingPhase 2/3
Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cholangiocarcinoma
Phase III Study of Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cholangiocarcinoma
Source: ClinicalTrials.gov · Last updated 1 Aug 2017
Brief summary (registry, in English)
The purpose of this study is to determine whether combining of radiofrequency ablation (RFA) and cytokine-induced killer cells (CIK) transfusion can prolong survival of patients with cholangiocarcinoma.
- Status (registry)
- Active, not recruiting
- Phase (registry)
- Phase 2/3
- Study type
- Interventional
- Enrollment
- 50 (actual)
- First submitted
- 24 Jun 2015
- Start date
- Jul 2012
- Primary completion date
- Jul 2030
- Lead sponsor
- The First People's Hospital of Changzhou
- Diseases
- Liver and biliary tract cancer
- NCT number
- NCT02482454
What you commit to
- Study type: Interventional · Phase 2/3
- Participants enrolled: 50
- From Jul 2012 to the primary completion date, Jul 2030
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- With other neoplastic disease that is measurable or being treated other than cholangiocarcinoma.
Other
- With extrahepatic metastases
Who the study is looking for
- Patients with histologically confirmed cholangiocarcinoma
- Primary lesions (cholangiocarcinoma) are not resected
- Serum bilirubin level of 2.0 mg/dl or less.
- Performance status of 0 or 1.
- Expected survival of 1 year or more.
- Informed consent from the patient.
Age in the registry: 30 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The First People's Hospital Of Changzhou Coordinator of this site? Confirm its status | Changzhou | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.